Comment: Trial updates from GALAXIES Lung-201 and RELATIVITY-104 in NSCLC
Prof Garbe presents, at a press conference at ASCO 2015, a randomised study finds that surgical removal of the lymph nodes surrounding a melanoma tumour after a positive lymph node biopsy (melanoma found in node) does not improve survival.
Read the news article and watch the interview for more.
Comment: Trial updates from GALAXIES Lung-201 and RELATIVITY-104 in NSCLC
Neoadjuvant daromun effective and safe for resectable, locally advanced melanoma
2 year recurrence free survival benefit for resectable melanoma treated with neoadjuvant/adjuvant pembrolizumab
Neoadjuvant cemiplimab shows favourable event-free, disease-free and overall survival rates in patients with resectable CSCC
Adding new vaccine type to leading immunotherapy dramatically reduces melanoma recurrence
SOFT study: Clinical relevance of genomic alterations in premenopausal HR+, HER2- early breast cancer
Gemcitabine, cisplatin plus nivolumab achieves clinical complete response in subset of muscle-invasive bladder cancer patients
The role of multidisciplinary tumour board in managing stage 3 lung cancer
NRG-GI002: A phase II clinical trial platform using total neoadjuvant therapy in locally advanced rectal cancer